Proteomics International names David Morris as CEO
SYDNEY: Proteomics International Laboratories Ltd (ASX: PIQ) announced on Wednesday the appointment of David Morris as Chief Executive Officer and Managing Director, effective January 19, 2026. Morris succeeds founder Dr. Richard Lipscombe, who will retire in February after 25 years leading the precision diagnostics company. Morris, a veteran healthcare and medical technology executive, has held…